Reducing drug related mortality in Europe - a seemingly intractable public health issue
DOI:
https://doi.org/10.20882/adicciones.111Keywords:
mortality, overdose, HIV, drug users, EuropeAbstract
Drawing on an analysis of data from over 30 cohort studies, it can be estimated that between 10.000 and 20.000 opioid users die each year in Europe. Typically, annual mortality rates are between 10–20/1000, representing an excess mortality 10 to 20 times greater than expected. Most deaths occur among males in their mid-thirties. Four broad categories of cause of death can be identified: overdoses, diseases, suicide and trauma. While the long term trend in HIV related mortality among drug users is downwards, other causes of mortality have shown little sign of decreasing in recent years. Of particular concern are overdoses which account for 6300 to 8400 deaths reported annually. The fact that deaths have not decreased is surprising given the scaling up of treatment and other services. Opioid substitution treatment in particular is known to be protective and the numbers of those in substitution treatment in Europe has increased dramatically. A number of interrelated factors may help explain this intractable problem. These include: the possibility of an aging cohort becoming more vulnerable; the use of alcohol and other drugs; high levels of ill-health, risk behaviour, and co-morbidity; and social exclusion and marginalisation. Reducing overall morbidity among heroin users remains a key issue for Europe’s public health services. More efforts are required to better understand and target both the direct and indirect factors associated with mortality among problem drugs users, if this major health cost associated with drug consumption is to be reduced.References
Bargagli, A. M., Davoli, M., Minozzi, S., Vecchi, S., & Perucci, C. A. (2007).
A Systematic Review of Observational Studies on Treatment of Opioid Dependence Geneva, Switzerland, WHO. Retrieved from: http://www.who.int/substance_abuse/activities/observational_
studies_treatment.pdf
Bargagli, A. M., Hickman, M., Davoli, M., Perucci, C. A., Schifano, P., Buster, M. et al. (2006). Drug-related mortality and its impact on adult mortality in eight European countries. European Journal of Public Health, 16, 198-202. doi:10.1093/eurpub/cki168
Brugal, M. T., Domingo-Salvany, A., Puig, R., Barrio, G., Garcia de, O. P., & de la Fuente, L. (2005). Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids
in a cohort of heroin users in Spain. Addiction, 100, 981-989.
doi:10.1111/j.1360-0443.2005.01089.x
Clausen, T., Anchersen, K., & Waal, H. (2008). Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug and Alcohol Dependence., 94, 151-157. doi:10.1016/j.drugalcdep.2007.11.003
Clausen, T., Waal, H., Thoresen, M., & Gossop, M. (2009). Mortality among opiate users: opioid maintenance therapy, age and causes of death. Addiction, 104, 1356-1362. doi:10.1111/j.1360-0443.2009.02570.x
Cornish, R., Macleod, J., Strang, J., Vickerman, P., & Hickman, M. (2010).
Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database. British Medical Journal, (7779), 928. doi:10.1136/bmj.c5475
Darke S, Degenhardt, L., & Mattick, R. (2007). Mortality amongst illicit
drug users: epidemiology, causes and interventions Cambridge University Press.
Darke, S., Williamson, A., Ross, J., & Teesson, M. (2005). Non-fatal heroin
overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS). Drug and Alcohol Review, 24, 425-432. doi:10.1080/09595230500286005
Davoli, M., Bargagli, A. M., Perucci, C. A., Schifano, P., Belleudi, V., Hickman, M.,.... VEdeTTE Study Group (2007). Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction, 102, 1954-1959. doi:10.1111/j.1360-0443.2007.02025.x
Degenhardt, L., Bucello, C., Mathers, B., Briegleb, C., Ali, H., Hickman, M. & McLaren, J. (2011a). Mortality among regular or dependent users of heroin and other opioids: a systematic review and metaanalysis of cohort studies. Addiction, 106, 32-51. doi:10.1111/j.1360-0443.2010.03140.x
Degenhardt, L., Randall, D., Hall, W., Law, M., Butler, T., & Burns, L.(2009).
Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug and Alcohol Dependendence, 105, 9-15. doi:10.1016/j.drugalcdep.2009.05.021
Degenhardt, L., Singleton, J., Calabria, B., McLaren, J., Kerr, T., Mehta, S.,...Hall, W.D. (2011b). Mortality among cocaine users: a systematic
review of cohort studies. Drug and Alcohol Dependence, 113, 88-95.
doi:10.1016/j.drugalcdep.2010.07.026
EMCDDA. (2011a). Mortality related to drug use in Europe: public health
implications Luxembourg: Publications Office of the European Union. Retrieved from: http://www.emcdda.europa.eu/publications/selected-issues/mortality
EMCDDA. (2011b). The state of the drugs problem in Europe. Annual
report 2011 Luxembourg: Publications Office of the European Union.
Retrieved from: http://www.emcdda.europa.eu/publications/annualreport/
EMCDDA, & ECDC. (2011). Joint ECDC and EMCDDA rapid risk assessment
HIV in Injecting Drug Users in the EU, following a reported increase of cases in Romania and Greece. doi:10.2810/50417 Retrieved from:
http://www.emcdda.europa.eu/html.cfm/index146510EN.html
Merrall, E. L., Kariminia, A., Binswanger, I. A., Hobbs, M. S., Farrell, M.,
Marsden, J.,... Bird, S. M. (2010). Meta-analysis of drug-related deaths soon after release from prison. Addiction, 105, 1545-1554.
doi:10.1111/j.1360-0443.2010.02990.x
Stenbacka, M., Leifman, A., & Romelsjo, A. (2010). Mortality and cause of
death among 1705 illicit drug users: a 37 year follow up. Drug and Alcohol Review, 29, 21-27. doi:10.1111/j.1465-3362.2009.00075.x
Talu, A., Rajaleid, K., Abel-Ollo, K., Ruutel, K., Rahu, M., Rhodes, T.,...
Uusküla, A. (2010). HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention. International Journal of Drug Policy, 21, 56-63. doi:10.1016/j.drugpo.2009.02.007
Vicente, J., Giraudon, I., Matias, J., Hedrich, D., & Wiessing, L. (2009).
Rebound of overdose mortality in the European Union 2003-2005: findings from the 2008 EMCDDA Annual Report. Euro. Surveill, 14(2).
WHO Regional Office for Europe. (2010). Prevention of acute drugrelated
mortality in prison populations during the immediate postrelease period. Copenhagen: WHO Regional Office for Europe. Retrieved from: http://www.euro.who.int/en/what-we-publish/abstracts/prevention-of-acute-drug-related-mortality-in-prisonpopulations-during-the-immediate-post-release-period
